Bellerophon Therapeutics, Inc. (11) | Uncategorized (4)
- Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 11, 2021)
- Open Market Sale AgreementSM, dated July 17, 2020, by and between Bellerophon Therapeutics, Inc. and Jefferies LLC (Filed With SEC on July 17, 2020)
- Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on April 6, 2020)
- Form of Engagement Letter (Filed With SEC on March 30, 2020)
